Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy

J Allergy Clin Immunol. 2020 Jun;145(6):1713-1715. doi: 10.1016/j.jaci.2020.02.002. Epub 2020 Feb 19.

¹ Global Medical, Global Specialty & Primary Care, Brentford, Middlesex, United Kingdom. Electronic address: [email protected].
² Yale Center for Asthma and Airways Disease (YCAAD), Yale School of Medicine, New Haven, Conn.
³ Value Evidence and Outcomes, GSK, Collegeville, Pa.
⁴ Respiratory Therapeutic Area, GSK, Research Triangle Park, NC.
⁵ Clinical Statistics, GSK, Uxbridge, Middlesex, United Kingdom.
⁶ Respiratory Medical Franchise, GSK, Research Triangle Park, NC.
⁷ Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium.
⁸ Upper Airways Research Laboratory, University Hospital Ghent, Ghent, Belgium.

No abstract available

Publication types